JNGLX
Price
$65.58
Change
-$0.68 (-1.03%)
Updated
Aug 6 closing price
Net Assets
4.4B
RCGHX
Price
$14.67
Change
-$0.20 (-1.34%)
Updated
Aug 6 closing price
Net Assets
97.55M
Interact to see
Advertisement

JNGLX vs RCGHX

Header iconJNGLX vs RCGHX Comparison
Open Charts JNGLX vs RCGHXBanner chart's image
Janus Henderson Global Life Sciences D
Price$65.58
Change-$0.68 (-1.03%)
VolumeN/A
Net Assets4.4B
Virtus KAR Health Sciences C
Price$14.67
Change-$0.20 (-1.34%)
VolumeN/A
Net Assets97.55M
JNGLX vs RCGHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JNGLX vs. RCGHX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Hold and RCGHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.4B vs. RCGHX (97.5M). JNGLX pays higher dividends than RCGHX: JNGLX (0.36) vs RCGHX (0.00). JNGLX was incepted earlier than RCGHX: JNGLX (27 years) vs RCGHX (24 years). RCGHX (2.14) is less costly to investors than JNGLX (0.80). JNGLX is a more actively managed with annual turnover of: 35.00 vs. RCGHX (6.00). JNGLX (2500) and RCGHX (2500) have matching initial minimum investment requirements. JNGLX annual gain was more profitable for investors over the last year : -13.54 vs. RCGHX (-14.39). JNGLX return over 5 years is better than : 1.85 vs. RCGHX (-44.29).
JNGLXRCGHXJNGLX / RCGHX
Total Expense Ratio0.802.1437%
Annual Report Gross Expense Ratio0.802.1437%
Fund Existence27 years24 years-
Gain YTD-2.401-7.69731%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets4.4B97.5M4,515%
Annual Yield % from dividends0.360.00-
Returns for 1 year-13.54-14.3994%
Returns for 3 years4.46-23.78-19%
Returns for 5 years1.85-44.29-4%
Returns for 10 years8.81-55.22-16%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RTNSX13.390.10
+0.75%
Russell Inv Tax-Managed Intl Eq S
BPAVX32.26N/A
N/A
Boston Partners All Cap Value Inv
SCOBX43.98N/A
N/A
DWS International Growth S
GMVCX15.54N/A
N/A
Goldman Sachs Small/Mid Cap Equity C
CMRCX10.47-0.02
-0.19%
Calamos Merger Arbitrage C